inclusion criteria: * normal or near-normal kidney function * history of confirmed covid-19 infection that preceded the post-covid symptoms * post-covid-19 symptoms persisting greater than three months * at least 2 post-covid symptoms of moderate or severe intensity (fatigue, brain fog, shortness of breath, body aches, gastrointestinal symptoms, or cardiovascular symptoms) * willing to report all vaccinations * women of childbearing potential or men whose partners may become pregnant must use acceptable method of contraception during the treatment period and for 28 days after the last dose of the study drug * willing and able to adhere to study procedures and available for the duration of the study

inclusion criteria: * normal or near-normal kidney function * history of confirmed covid-19 infection that preceded the post-covid symptoms * post-covid-19 symptoms persisting greater than three months * at least 2 post-covid symptoms of moderate or severe intensity (fatigue, brain fog, shortness of breath, body aches, gastrointestinal symptoms, or cardiovascular symptoms) * willing to report all vaccinations * women of childbearing potential or men whose partners may become pregnant must use acceptable method of contraception during the treatment period and for 28 days after the last dose of the study drug * willing and able to adhere to study procedures and available for the duration of the study

inclusion criteria: normal or near-normal kidney function history of confirmed covid-19 infection that preceded the post-covid symptoms post-covid-19 symptoms persisting greater than three months at least 2 post-covid symptoms of moderate of severe intensity (fatigue, brain fog, shortness of breath, body aches, gastrointestinal symptoms, or cardiovascular symptoms) willing to report all vaccinations women of childbearing potential or men whose partners may become pregnant must use acceptable method of contraception during the treatment period and for 28 days after the last dose of the study drug willing and able to adhere to study procedures and available for the duration of the study

inclusion criteria: normal or near-normal kidney function history of confirmed covid-19 infection that preceded the post-covid symptoms post-covid-19 symptoms persisting greater than three months at least 2 post-covid symptoms of moderate of severe intensity (fatigue, brain fog, shortness of breath, body aches, gastrointestinal symptoms, or cardiovascular symptoms) willing to report all vaccinations women of childbearing potential or men whose partners may become pregnant must use acceptable method of contraception during the treatment period and for 28 days after the last dose of the study drug willing and able to adhere to study procedures and available for the duration of the study

inclusion criteria: normal or near-normal kidney function history of confirmed covid-19 infection post-covid-19 symptoms persisting greater than three months

inclusion criteria: normal or near-normal kidney function history of confirmed covid-19 infection post-covid-19 symptoms persisting greater than three months